 |
 |
|
|
|
| Gefitinib |
 |
| Gefitinib |
 |
Gefitinib
Alias:Iressa
GEFITINIB
AKOS 91371
n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine
ZD 1839
4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-
Gefitinib(TINIBS)
Gefitinib, Iressa, ZD1839
Gefitinib Base
CAS:184475-35-2
Content: 99.5%
Character: Powder
Molecular formula C22H24ClFN4O3
Molecular weight: 446.9024
Use: the use of non small cell lung cancer (), which is suitable for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC), which has been treated with chemotherapy or not.
Packing: 1kg/ aluminum foil bag
Delivery: Express courier.
More information,pls contact:
Email:2355935207@yuanchengtech.com
Skype:the.heart667
Tel:027-50756157
Fax:027-68886696-874
|
 |
Gefitinib
Alias:Iressa
GEFITINIB
AKOS 91371
n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine
ZD 1839
4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-
Gefitinib(TINIBS)
Gefitinib, Iressa, ZD1839
Gefitinib Base
CAS:184475-35-2
Content: 99.5%
Character: Powder
Molecular formula C22H24ClFN4O3
Molecular weight: 446.9024
Use: the use of non small cell lung cancer (), which is suitable for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC), which has been treated with chemotherapy or not.
Packing: 1kg/ aluminum foil bag
Delivery: Express courier.
More information,pls contact:
Email:2355935207@yuanchengtech.com
Skype:the.heart667
Tel:027-50756157
Fax:027-68886696-874
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
